SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parnax Lab - Quaterly Results

27 May 2025 Evaluate
The sales is pegged at Rs. 8.37 millions for the March 2025 quarter. The mentioned figure indicates a decline of about -51.00% as against Rs. 17.08 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -0.85 millions as compared to Net Profit of Rs. 1.74 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -0.92% as compared to 2.74% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 8.37 17.08 -51.00 70.19 74.40 -5.66 70.19 74.40 -5.66
Other Income 1.89 1.15 64.35 7.10 5.35 32.71 7.10 5.35 32.71
PBIDT -0.92 2.74 -133.58 19.46 26.47 -26.48 19.46 26.47 -26.48
Interest 0.05 0.17 -70.59 0.24 1.41 -82.98 0.24 1.41 -82.98
PBDT -0.97 2.57 -137.74 19.22 25.06 -23.30 19.22 25.06 -23.30
Depreciation 0.16 0.15 6.67 0.63 0.58 8.62 0.63 0.58 8.62
PBT -1.13 2.42 -146.69 18.59 24.48 -24.06 18.59 24.48 -24.06
TAX -0.28 0.68 -141.18 4.64 6.23 -25.52 4.64 6.23 -25.52
Deferred Tax -0.28 0.68 -141.18 4.64 6.23 -25.52 4.64 6.23 -25.52
PAT -0.85 1.74 -148.85 13.95 18.25 -23.56 13.95 18.25 -23.56
Equity 114.86 114.86 0.00 114.86 114.86 0.00 114.86 114.86 0.00
PBIDTM(%) -10.99 16.04 -168.52 27.72 35.58 -22.07 27.72 35.58 -22.07

Parnax Lab Share Price

161.00 3.75 (2.38%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×